Journal of Biological Chemistry
Volume 285, Issue 13, 26 March 2010, Pages 10044-10052
Journal home page for Journal of Biological Chemistry

Cell Biology
Revelation of p53-independent Function of MTA1 in DNA Damage Response via Modulation of the p21WAF1-Proliferating Cell Nuclear Antigen Pathway*

https://doi.org/10.1074/jbc.M109.079095Get rights and content
Under a Creative Commons license
open access

Although metastasis-associated protein 1 (MTA1), a component of the nucleosome remodeling and deacetylase (NuRD) complex, is a DNA-damage response protein and regulates p53-dependent DNA repair, it remains unknown whether MTA1 also participates in p53-independent DNA damage response. Here, we provide evidence that MTA1 is a p53-independent transcriptional corepressor of p21WAF1, and the underlying mechanism involves recruitment of MTA1-histone deacetylase 2 (HDAC2) complexes onto two selective regions of the p21WAF1 promoter. Accordingly, MTA1 depletion, despite its effect on p53 down-regulation, superinduces p21WAF1, increases p21WAF1 binding to proliferating cell nuclear antigen (PCNA), and decreases the nuclear accumulation of PCNA in response to ionizing radiation. In support of a p53-independent role of MTA1 in DNA damage response, we further demonstrate that induced expression of MTA1 in p53-null cells inhibits p21WAF1 promoter activity and p21WAF1 binding to PCNA. Consequently, MTA1 expression in p53-null cells results in increased induction of γH2AX foci and DNA double strand break repair, and decreased DNA damage sensitivity following ionizing radiation treatment. These findings uncover a new target of MTA1 and the existence of an additional p53-independent role of MTA1 in DNA damage response, at least in part, by modulating the p21WAF1-PCNA pathway, and thus, linking two previously unconnected NuRD complex and DNA-damage response pathways.

Cancer
Diseases/Cancer/Therapy
DNA/Damage
DNA/Repair
Gene/Transcription
Transcription/Repressor

Cited by (0)

*

This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R. K.).

The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2.

1

Both authors contributed equally to this work.

2

Present address: Dept. of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030.